SHANNON TIMOTHY M
Insider CIK 1207114 · CTMX Director · ARVN Director · NXTC Director · IDYA Director · RLYB Director · CLDX Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| IDYA IDEAYA Biosciences, Inc. | A Award deriv | 2023-06-07 | 2023-06-09 | 16,200 | — | $0 | 16,200 | SEC↗ |
| ARVN ARVINAS, INC. | A Award deriv | 2022-06-16 | 2022-06-21 | 10,192 | — | $0 | 10,192 | SEC↗ |
| IDYA IDEAYA Biosciences, Inc. | A Award deriv | 2022-06-09 | 2022-06-10 | 11,000 | — | $0 | 11,000 | SEC↗ |
| RLYB Rallybio Corp | A Award deriv | 2022-01-03 | 2022-01-05 | 6,041 | — | $0 | 6,041 | SEC↗ |
| ARVN ARVINAS, INC. | S Sale | 2021-09-07 | 2021-09-27 | 14,751 | $87.98 | $1.30M | 1,674,788 | SEC↗ |
| ARVN ARVINAS, INC. | S Sale | 2021-09-07 | 2021-09-27 | 2,030 | $90.75 | $184.2K | 1,653,128 | SEC↗ |
| ARVN ARVINAS, INC. | S Sale | 2021-09-07 | 2021-09-27 | 14,163 | $90.08 | $1.28M | 1,655,158 | SEC↗ |
| ARVN ARVINAS, INC. | S Sale | 2021-09-07 | 2021-09-27 | 5,467 | $88.90 | $486.0K | 1,669,321 | SEC↗ |
| ARVN ARVINAS, INC. | S Sale | 2021-09-03 | 2021-09-27 | 30,068 | $85.47 | $2.57M | 1,691,858 | SEC↗ |
| ARVN ARVINAS, INC. | S Sale | 2021-09-03 | 2021-09-27 | 2,319 | $86.39 | $200.3K | 1,689,539 | SEC↗ |
| ARVN ARVINAS, INC. | S Sale | 2021-09-02 | 2021-09-27 | 28,449 | $85.42 | $2.43M | 1,745,242 | SEC↗ |
| ARVN ARVINAS, INC. | S Sale | 2021-09-02 | 2021-09-27 | 23,316 | $86.34 | $2.01M | 1,721,926 | SEC↗ |
| ARVN ARVINAS, INC. | S Sale | 2021-09-01 | 2021-09-27 | 11,863 | $88.59 | $1.05M | 1,773,691 | SEC↗ |
| ARVN ARVINAS, INC. | S Sale | 2021-09-01 | 2021-09-27 | 19,275 | $87.86 | $1.69M | 1,785,554 | SEC↗ |
| ARVN ARVINAS, INC. | S Sale | 2021-09-01 | 2021-09-27 | 18,821 | $85.67 | $1.61M | 1,834,307 | SEC↗ |
| ARVN ARVINAS, INC. | S Sale | 2021-09-01 | 2021-09-27 | 29,478 | $86.79 | $2.56M | 1,804,829 | SEC↗ |
| ARVN ARVINAS, INC. | S Sale | 2021-08-31 | 2021-09-27 | 47,166 | $85.39 | $4.03M | 1,865,317 | SEC↗ |
| ARVN ARVINAS, INC. | S Sale | 2021-08-31 | 2021-09-27 | 12,189 | $86.21 | $1.05M | 1,853,128 | SEC↗ |
| ARVN ARVINAS, INC. | S Sale | 2021-08-30 | 2021-09-27 | 24,607 | $85.19 | $2.10M | 1,946,714 | SEC↗ |
| ARVN ARVINAS, INC. | S Sale | 2021-08-30 | 2021-09-27 | 25,469 | $86.40 | $2.20M | 1,921,245 | SEC↗ |
| ARVN ARVINAS, INC. | S Sale | 2021-08-30 | 2021-09-27 | 7,581 | $87.51 | $663.4K | 1,913,664 | SEC↗ |
| ARVN ARVINAS, INC. | S Sale | 2021-08-30 | 2021-09-27 | 1,181 | $88.22 | $104.2K | 1,912,483 | SEC↗ |
| ARVN ARVINAS, INC. | S Sale | 2021-08-27 | 2021-09-27 | 42,655 | $85.38 | $3.64M | 1,973,692 | SEC↗ |
| ARVN ARVINAS, INC. | S Sale | 2021-08-27 | 2021-09-27 | 2,371 | $86.06 | $204.0K | 1,971,321 | SEC↗ |
| ARVN ARVINAS, INC. | S Sale | 2021-08-26 | 2021-09-27 | 11,712 | $85.12 | $996.9K | 2,016,347 | SEC↗ |
| ARVN ARVINAS, INC. | S Sale | 2021-08-25 | 2021-09-27 | 14,267 | $85.03 | $1.21M | 2,028,059 | SEC↗ |
| ARVN ARVINAS, INC. | S Sale | 2021-08-24 | 2021-09-27 | 4,635 | $87.08 | $403.6K | 2,042,326 | SEC↗ |
| ARVN ARVINAS, INC. | S Sale | 2021-08-24 | 2021-09-27 | 4,568 | $86.95 | $397.2K | 2,046,961 | SEC↗ |
| ARVN ARVINAS, INC. | S Sale | 2021-08-23 | 2021-09-27 | 1,599 | $88.01 | $140.7K | 2,051,529 | SEC↗ |
| RLYB Rallybio Corp | P Buy | 2021-08-02 | 2021-08-04 | 76,923 | $13.00 | $1000.0K | 2,409,712 | SEC↗ |
| RLYB Rallybio Corp | J Other deriv | 2021-07-28 | 2021-08-04 | 4,315,676 | — | $0 | 0 | SEC↗ |
| RLYB Rallybio Corp | J Other deriv | 2021-07-28 | 2021-08-04 | 8,742,654 | — | $0 | 0 | SEC↗ |
| RLYB Rallybio Corp | J Other deriv | 2021-07-28 | 2021-08-04 | 1,795,946 | — | $0 | 0 | SEC↗ |
| RLYB Rallybio Corp | A Award deriv | 2021-07-28 | 2021-08-04 | 13,440 | — | $0 | 13,440 | SEC↗ |
| RLYB Rallybio Corp | J Other | 2021-07-28 | 2021-08-04 | 2,332,789 | — | $0 | 2,332,789 | SEC↗ |
| IDYA IDEAYA Biosciences, Inc. | A Award deriv | 2021-06-10 | 2021-06-16 | 11,000 | — | $0 | 11,000 | SEC↗ |
| ARVN ARVINAS, INC. | A Award deriv | 2021-06-08 | 2021-06-10 | 7,511 | — | $0 | 7,511 | SEC↗ |
| ARVN ARVINAS, INC. | P Buy | 2020-06-17 | 2020-06-19 | 2,000 | $30.26 | $60.5K | 79,546 | SEC↗ |
| IDYA IDEAYA Biosciences, Inc. | A Award deriv | 2020-06-16 | 2020-06-18 | 11,000 | — | $0 | 11,000 | SEC↗ |
| ARVN ARVINAS, INC. | A Award deriv | 2020-06-03 | 2020-06-04 | 12,000 | — | $0 | 12,000 | SEC↗ |
| ARVN ARVINAS, INC. | P Buy | 2020-06-02 | 2020-06-04 | 3,000 | $32.30 | $96.9K | 77,546 | SEC↗ |
| ARVN ARVINAS, INC. | M Exercise deriv | 2020-05-26 | 2020-05-26 | 12,923 | — | $0 | 0 | SEC↗ |
| ARVN ARVINAS, INC. | M Exercise | 2020-05-26 | 2020-05-26 | 12,923 | $22.06 | $285.1K | 74,546 | SEC↗ |
| ARVN ARVINAS, INC. | P Buy | 2020-03-20 | 2020-03-23 | 2,500 | $40.00 | $100.0K | 61,623 | SEC↗ |
| IDYA IDEAYA Biosciences, Inc. | A Award deriv | 2019-09-24 | 2019-12-19 | 11,000 | — | $0 | 11,000 | SEC↗ |
| NXTC NextCure, Inc. | A Award deriv | 2019-06-13 | 2019-06-17 | 22,000 | — | $0 | 22,000 | SEC↗ |
| IDYA IDEAYA Biosciences, Inc. | C Conversion deriv | 2019-05-28 | 2019-05-28 | 602,549 | — | $0 | 0 | SEC↗ |
| IDYA IDEAYA Biosciences, Inc. | C Conversion deriv | 2019-05-28 | 2019-05-28 | 1,658,164 | — | $0 | 0 | SEC↗ |
| IDYA IDEAYA Biosciences, Inc. | P Buy | 2019-05-28 | 2019-05-28 | 400,000 | $10.00 | $4.00M | 2,660,713 | SEC↗ |
| IDYA IDEAYA Biosciences, Inc. | C Conversion | 2019-05-28 | 2019-05-28 | 602,549 | — | $0 | 2,260,713 | SEC↗ |
| IDYA IDEAYA Biosciences, Inc. | C Conversion | 2019-05-28 | 2019-05-28 | 1,658,164 | — | $0 | 1,658,164 | SEC↗ |
| ARVN ARVINAS, INC. | A Award deriv | 2019-05-23 | 2019-05-28 | 12,923 | — | $0 | 12,923 | SEC↗ |
| NXTC NextCure, Inc. | C Conversion deriv | 2019-05-13 | 2019-05-13 | 2,296,605 | — | $0 | 0 | SEC↗ |
| NXTC NextCure, Inc. | C Conversion deriv | 2019-05-13 | 2019-05-13 | 5,861,455 | — | $0 | 0 | SEC↗ |
| NXTC NextCure, Inc. | C Conversion deriv | 2019-05-13 | 2019-05-13 | 5,970,000 | — | $0 | 0 | SEC↗ |
| NXTC NextCure, Inc. | C Conversion deriv | 2019-05-13 | 2019-05-13 | 3,582,000 | — | $0 | 0 | SEC↗ |
| NXTC NextCure, Inc. | P Buy | 2019-05-13 | 2019-05-13 | 50,000 | $15.00 | $750.0K | 2,254,442 | SEC↗ |
| NXTC NextCure, Inc. | C Conversion | 2019-05-13 | 2019-05-13 | 445,866 | — | $0 | 445,866 | SEC↗ |
| NXTC NextCure, Inc. | C Conversion | 2019-05-13 | 2019-05-13 | 743,110 | — | $0 | 1,188,976 | SEC↗ |
| NXTC NextCure, Inc. | C Conversion | 2019-05-13 | 2019-05-13 | 729,599 | — | $0 | 1,918,575 | SEC↗ |
| NXTC NextCure, Inc. | C Conversion | 2019-05-13 | 2019-05-13 | 285,867 | — | $0 | 2,204,442 | SEC↗ |
| ARVN ARVINAS, INC. | P Buy | 2019-03-28 | 2019-04-01 | 3,500 | $14.69 | $51.4K | 58,898 | SEC↗ |
| ARVN ARVINAS INC. | C Conversion deriv | 2018-10-01 | 2018-10-03 | 4,462,837 | — | $0 | 0 | SEC↗ |
| ARVN ARVINAS INC. | C Conversion deriv | 2018-10-01 | 2018-10-03 | 9,543,387 | — | $0 | 0 | SEC↗ |
| ARVN ARVINAS INC. | C Conversion deriv | 2018-10-01 | 2018-10-03 | 2,209,833 | — | $0 | 0 | SEC↗ |
| ARVN ARVINAS INC. | C Conversion | 2018-10-01 | 2018-10-03 | 4,989,554 | — | $0 | 4,989,554 | SEC↗ |
| ARVN ARVINAS INC. | P Buy | 2018-10-01 | 2018-10-03 | 4,000 | $16.00 | $64.0K | 55,398 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | S Sale | 2016-11-29 | 2016-12-01 | 22,086 | $11.18 | $246.9K | 3,244,381 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | S Sale | 2016-11-28 | 2016-11-28 | 20,840 | $11.33 | $236.1K | 3,666,467 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | S Sale | 2016-11-25 | 2016-11-28 | 6,729 | $11.79 | $79.3K | 3,687,307 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | S Sale | 2016-11-23 | 2016-11-28 | 10,890 | $11.84 | $128.9K | 3,694,036 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | S Sale | 2016-11-22 | 2016-11-22 | 42,550 | $11.71 | $498.3K | 3,704,926 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | S Sale | 2016-11-21 | 2016-11-21 | 13,548 | $11.72 | $158.8K | 3,747,476 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | S Sale | 2016-11-18 | 2016-11-21 | 12,805 | $11.64 | $149.1K | 3,761,024 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | S Sale | 2016-11-17 | 2016-11-21 | 18,971 | $11.50 | $218.2K | 3,773,829 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | S Sale | 2016-11-16 | 2016-11-16 | 18,517 | $11.55 | $213.9K | 3,792,800 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | S Sale | 2016-11-15 | 2016-11-16 | 33,064 | $11.48 | $379.6K | 3,811,317 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | S Sale | 2016-11-14 | 2016-11-14 | 23,744 | $11.21 | $266.2K | 3,844,381 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | S Sale | 2016-11-11 | 2016-11-14 | 35,391 | $11.20 | $396.4K | 3,868,125 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | S Sale | 2016-11-10 | 2016-11-14 | 27,135 | $11.07 | $300.4K | 3,903,516 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | S Sale | 2016-11-09 | 2016-11-10 | 13,730 | $11.03 | $151.4K | 3,930,651 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | A Award deriv | 2016-06-10 | 2016-06-14 | 14,000 | — | $0 | 14,000 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | S Sale | 2016-06-10 | 2016-06-10 | 2,700 | $10.01 | $27.0K | 4,244,381 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | S Sale | 2016-06-09 | 2016-06-10 | 22,842 | $10.06 | $229.8K | 4,247,081 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | S Sale | 2016-06-08 | 2016-06-10 | 22,885 | $10.08 | $230.7K | 4,269,923 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | S Sale | 2016-06-07 | 2016-06-08 | 9,731 | $10.03 | $97.6K | 4,292,808 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | S Sale | 2016-06-06 | 2016-06-08 | 101,767 | $10.01 | $1.02M | 4,302,539 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | S Sale | 2016-06-03 | 2016-06-06 | 18,428 | $10.83 | $199.6K | 4,404,306 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | S Sale | 2016-06-02 | 2016-06-06 | 41,193 | $10.79 | $444.5K | 4,422,734 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | S Sale | 2016-06-01 | 2016-06-02 | 22,463 | $10.75 | $241.5K | 4,463,927 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | S Sale | 2016-05-27 | 2016-06-01 | 25,082 | $10.60 | $265.9K | 4,486,390 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | S Sale | 2016-05-26 | 2016-05-27 | 39,887 | $10.43 | $416.0K | 4,511,472 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | S Sale | 2016-05-25 | 2016-05-27 | 11,456 | $10.02 | $114.8K | 4,551,359 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | S Sale | 2016-05-24 | 2016-05-25 | 1,200 | $10.00 | $12.0K | 4,562,815 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | S Sale | 2016-05-23 | 2016-05-25 | 12,053 | $10.10 | $121.7K | 4,564,015 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | S Sale | 2016-05-20 | 2016-05-23 | 6,187 | $10.09 | $62.4K | 4,576,068 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | S Sale | 2016-05-19 | 2016-05-23 | 2,500 | $10.14 | $25.4K | 4,582,255 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | C Conversion deriv | 2015-10-14 | 2015-10-16 | 3,566,337 | — | $0 | 0 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | C Conversion deriv | 2015-10-14 | 2015-10-16 | 1,318,418 | — | $0 | 0 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | C Conversion | 2015-10-14 | 2015-10-16 | 1,318,418 | — | $0 | 1,318,418 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | C Conversion | 2015-10-14 | 2015-10-16 | 3,566,337 | — | $0 | 3,566,337 | SEC↗ |
| CLDX Celldex Therapeutics, Inc. | A Award deriv | 2014-06-04 | 2014-06-05 | 2,000 | — | $0 | 2,000 | SEC↗ |
| CLDX Celldex Therapeutics, Inc. | A Award | 2014-06-04 | 2014-06-05 | 2,000 | — | $0 | 83,212 | SEC↗ |
| CLDX Celldex Therapeutics, Inc. | A Award deriv | 2013-06-19 | 2013-06-20 | 2,000 | — | $0 | 2,000 | SEC↗ |
| CLDX Celldex Therapeutics, Inc. | A Award | 2013-06-19 | 2013-06-20 | 2,000 | — | $0 | 81,212 | SEC↗ |
| CLDX Celldex Therapeutics, Inc. | A Award | 2012-06-20 | 2012-06-21 | 2,000 | — | $0 | 79,212 | SEC↗ |